First-line treatment includes trastuzumab (Herceptin, Genentech) plus chemotherapy. Some patients also receive pembrolizumab (Keytruda, Merck). However, “most patients experience disease ...

and another that’s like Genentech’s breast cancer drug Herceptin, which she launched in 2017 after a friend was diagnosed and struggled to afford the course of treatment. Herceptin cost nearly ...

Roche’s Genentech unit signed a trio of deals this ... competition for its ‘big three’ antibodies – Rituxan, Herceptin and Avastin – which together accounted for more than a third ...

Genentech produces a variety of drugs treating cancers and rare diseases, like Avastin for colorectal cancer and Herceptin for breast cancer. Driving the news: North Carolina approved a Job ...

Researchers at ASCO's annual meeting also discussed the importance of repeat biopsies to assess HER2 status after first-line ...

Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

– Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing multiple ...

If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Herceptin SC? Herceptin SC contains the active ingredient trastuzumab. Herceptin SC is used to ...

- Columvi is the first bispecific antibody to show a statistically significant and clinically meaningful 41% survival benefit in R/R DLBCL in the Phase III STARGLO study - - There is an urgent ...